Ehlers-Danlos syndrome type 1
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Skin and Connective Tissue Diseases; Hemic and Lymphatic Diseases; Cardiovascular Diseases
|
Disease or Syndrome
|
4
|
|
0.730 |
strong |
1.000 |
7 |
|
1996 |
2010 |
EHLERS-DANLOS SYNDROME, CLASSIC TYPE, 1
|
disease |
|
Disease or Syndrome
|
5
|
81
|
0.600 |
None |
1.000 |
11 |
38
|
1993 |
2018 |
Ehlers-Danlos syndrome type 2
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Skin and Connective Tissue Diseases; Hemic and Lymphatic Diseases; Cardiovascular Diseases
|
Disease or Syndrome
|
4
|
|
0.530 |
strong |
1.000 |
5 |
|
1995 |
1998 |
Familial thoracic aortic aneurysm and aortic dissection
|
disease |
|
Disease or Syndrome
|
59
|
442
|
0.400 |
limited |
|
0 |
1
|
|
|
Ehlers-Danlos Syndrome, Autosomal Dominant, Type Unspecified
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Skin and Connective Tissue Diseases; Hemic and Lymphatic Diseases; Cardiovascular Diseases
|
Disease or Syndrome
|
3
|
|
0.300 |
None |
1.000 |
2 |
|
2005 |
2012 |
Keloid
|
disease |
Pathological Conditions, Signs and Symptoms; Skin and Connective Tissue Diseases
|
Acquired Abnormality
|
165
|
15
|
0.300 |
None |
1.000 |
1 |
|
2010 |
2010 |
Liver Cirrhosis, Experimental
|
disease |
Pathological Conditions, Signs and Symptoms; Digestive System Diseases
|
Experimental Model of Disease
|
870
|
|
0.300 |
None |
1.000 |
1 |
|
2014 |
2014 |
Carcinomatosis
|
phenotype |
Neoplasms
|
Neoplastic Process
|
186
|
2
|
0.300 |
None |
1.000 |
1 |
|
2002 |
2002 |
Undifferentiated carcinoma
|
disease |
Neoplasms
|
Neoplastic Process
|
283
|
8
|
0.300 |
None |
1.000 |
1 |
|
2002 |
2002 |
Carcinoma, Spindle-Cell
|
disease |
Neoplasms
|
Neoplastic Process
|
218
|
5
|
0.300 |
None |
1.000 |
1 |
|
2002 |
2002 |
Anaplastic carcinoma
|
disease |
Neoplasms
|
Neoplastic Process
|
232
|
3
|
0.300 |
None |
1.000 |
1 |
|
2002 |
2002 |
Prostatic Neoplasms
|
group |
Neoplasms; Male Urogenital Diseases
|
Neoplastic Process
|
1722
|
31
|
0.300 |
None |
1.000 |
1 |
|
2018 |
2018 |
Ehlers-Danlos syndrome classic type
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Skin and Connective Tissue Diseases; Hemic and Lymphatic Diseases; Cardiovascular Diseases
|
Disease or Syndrome
|
2
|
|
0.300 |
strong |
1.000 |
1 |
|
2015 |
2015 |
Mammary Neoplasms, Experimental
|
phenotype |
Neoplasms
|
Neoplastic Process; Experimental Model of Disease
|
218
|
|
0.300 |
None |
1.000 |
1 |
|
2002 |
2002 |
Animal Mammary Neoplasms
|
phenotype |
Neoplasms; Animal Diseases
|
Neoplastic Process
|
147
|
|
0.300 |
None |
1.000 |
1 |
|
2002 |
2002 |
Spontaneous abortion
|
phenotype |
Female Urogenital Diseases and Pregnancy Complications
|
Pathologic Function
|
188
|
|
0.300 |
None |
1.000 |
1 |
|
2008 |
2008 |
Mammary Carcinoma, Animal
|
disease |
Neoplasms; Animal Diseases
|
Neoplastic Process
|
144
|
|
0.300 |
None |
1.000 |
1 |
|
2002 |
2002 |
Autoimmune Lymphoproliferative Syndrome Type 2B
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Immune System Diseases; Hemic and Lymphatic Diseases
|
Disease or Syndrome
|
14
|
2
|
0.300 |
strong |
1.000 |
1 |
|
1997 |
1997 |
Bleeding tendency
|
phenotype |
Hemic and Lymphatic Diseases
|
Pathologic Function
|
71
|
14
|
0.300 |
strong |
1.000 |
1 |
|
2015 |
2015 |
Blood Coagulation Disorders
|
group |
Hemic and Lymphatic Diseases
|
Disease or Syndrome
|
267
|
31
|
0.300 |
strong |
1.000 |
1 |
|
2015 |
2015 |
Malignant neoplasm of prostate
|
disease |
Neoplasms; Male Urogenital Diseases
|
Neoplastic Process
|
4502
|
1082
|
0.300 |
None |
1.000 |
1 |
|
2018 |
2018 |
Early Pregnancy Loss
|
phenotype |
Female Urogenital Diseases and Pregnancy Complications
|
Finding
|
109
|
|
0.300 |
None |
1.000 |
1 |
|
2008 |
2008 |
Miscarriage
|
disease |
Female Urogenital Diseases and Pregnancy Complications
|
Disease or Syndrome
|
426
|
56
|
0.300 |
None |
1.000 |
1 |
|
2008 |
2008 |
Abortion, Tubal
|
phenotype |
Female Urogenital Diseases and Pregnancy Complications
|
Pathologic Function
|
109
|
|
0.300 |
None |
1.000 |
1 |
|
2008 |
2008 |
Carcinoma
|
group |
Neoplasms
|
Neoplastic Process
|
2462
|
103
|
0.300 |
None |
1.000 |
1 |
|
2002 |
2002 |